Randomised controlled trial of physiological and ventricular pacing

The future of single chamber pacing

Although dual chamber pacemakers have held much interest in pacing over the past several years, single chamber pacing remains the modality of choice, worldwide, in the greatest proportion of patients. Atrial or ventricular demand pacing is safe and effective in the majority of patients. In addition, sensors may be used to increase ventricular pacing rate in order to improve cardiac performance.

Holter-monitored heart rhythm during atrioventricular synchronous and fixed-rate ventricular pacing

The purpose of this investigation was to study rate variability during normal everyday activities among physiologically paced patients. A comparison of the spontaneous occurrence of arrhythmias with ventricular inhibited pacing was also made. VDD pacemakers in 44 patients were randomly programmed to three-week long periods of VVI (70 bpm) or VDD (back-up rate 40-50 bpm, upper rate 125-150 bpm) pacing, respectively. A Holter ECG was recorded during the last 24 hours of each period. Although the total number of QRS complexes was similar in the two pacing modes (4.3 X 10(6)/24 hours), the rate span was extensively utilized during VDD pacing. During VDD pacing, only five patients of 39 with a programmed upper rate of 150 bpm reached this limit, while one of five with 125 bpm reached that rate. Occasional episodes of pacing at the back-up rate of 40 or 50 bpm were recorded in 33 patients. Episodes of asymptomatic rhythm disturbances were recorded in both pacing modes. No significant differences existed as regards ventricular tachyarrhythmias between the two modes of pacing and it did not seem that the incidence was higher than could be expected in a patient population of the present age. Since severe AV block does not permit conduction of atrial impulses during VVI pacing, no direct comparison between the two pacing modes can be made concerning atrial tachyarrhythmias. Only one episode of pacemaker-mediated SVT was found, and this was unsymptomatic.

Rate control of physiologic pacemakers by central venous blood temperature

Heart rate and central venous blood temperature (CVT) were measured in 31 people with different exercise capacities by means of a thermistor integrated into a lead that was placed in the right ventricle. Bicycle ergometric and treadmill stress tests with increasing workloads were performed. The maximum increase in CVT with ergometric exercise was found to be 1.3 degrees C at 250 W in healthy young volunteers and 1.0 degrees C at 125 W in cardiac patients. Despite a relatively greater increase in CVT in the elderly patients compared with the volunteers, the correlation between the increase in CVT and that in heart rate at the end of each exercise stage was found to be very high (r = .9693 in volunteers and r = .9864 in cardiac patients), independent of physical fitness. Even with everyday activities such as walking there was a marked increase in CVT. Due to its close relationship to human metabolism, CVT represents a good parameter for physiologic control of pacing rate.

Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: role of contractility

Although atrial synchronous and rate-responsive ventricular pacing have been compared, the importance of maintaining synchronized atrial systole in addition to rate responsiveness has been incompletely defined. That is, the effects of these two pacing modes on cardiac volumes and contractility have not been studied. Accordingly, 16 patients with normal ventricular function were studied while in the upright position and at rest with gated radionuclide ventriculography during both atrial synchronous and ventricular pacing. Twelve of these patients were also studied during low-level upright exercise (300 kilopond-meters). Rest and exercise ventricular pacing heart rates were matched to those recorded with synchronous pacing. Ventricular volumes were determined with a counts-based method. The ejection fraction and peak systolic pressure/end-systolic volumes or contractility between the two pacing modes. However, during exercise to identical heart rates, blood pressures, and workloads, although stroke volume was the same during exercise with atrial synchronous and ventricular pacing (78 +/- 13 vs 75 +/- 12 ml), end-diastolic and end-systolic volumes were lower with ventricular pacing than with atrial synchronous pacing (end-diastolic volume 101 +/- 13 vs 113 +/- 16 ml, p less than .001; end-systolic volume 26 +/- 4 vs 35 +/- 7 ml, p less than .001). Stroke volume during ventricular paced exercise was maintained at atrial synchronous pacing levels by means of increased contractility (ejection fraction of 74 +/- 4% during ventricular pacing vs 69 +/- 5% during atrial synchronous pacing, p = .002; peak systolic pressure/end-systolic volume ratio of 6.51 +/- 1 during ventricular pacing vs 4.85 +/- 1 during atrial synchronous pacing, p less than .001).(ABSTRACT TRUNCATED AT 250 WORDS)

A time-related study of the hemodynamic benefit of atrioventricular synchronous pacing evaluated by Doppler echocardiography

We have used Doppler echocardiography to estimate the stroke volume (SV) in a study of 13 patients equipped with DDD pacemakers. SV was measured both during DDD and VVI pacing after observation times of 1,3,6, and 12 months of DDD pacing. SV was also measured at seven atrioventricular (AV) intervals (75-250 ms) in the search for optimal AV intervals. Mitral flow velocity was investigated to see if DDD pacing resulted in synchronous atrial contraction, and if mitral insufficiency existed at any of the pacing modes. Compared with the VVI mode, DDD pacing resulted in a mean increase in SV of 21 +/- 2% for the four observation periods. Two patients with severe left ventricular failure had no significant increase in SV during DDD vs VVI pacing. In each patient, an optimal AV interval ranging between 100-250 ms for the SV was found. Velocity profiles of mitral flow showed synchronous atrial contraction during DDD pacing, but not during VVI pacing. Mitral insufficiency was not seen in any pacing mode. DDD pacing resulted in a reduction in SV during the first 6 months, and was constant thereafter. Doppler echocardiography can be used repeatedly to evaluate the hemodynamic response of DDD pacing vs VVI pacing, and to find which AV interval gives the highest SV in the individual patient. Our study further shows that the hemodynamic benefit of DDD pacing is present after short-term as well as after long-term DDD pacing.

Improved method for evaluating ventriculoatrial conduction before implantation of atrial-sensing dual chamber pacemakers

Pacemaker-mediated tachycardia may occur when a spontaneous ventricular premature depolarization is retrogradely conducted to the atrium with a ventriculoatrial (VA) interval that exceeds the atrial refractory period of an atrial-sensing dual chamber pacemaker. Previous methods for evaluating VA conduction have failed to predict clinical occurrences of pacemaker-mediated tachycardia. In this study, maximal VA intervals after ventricular extrastimuli during atrial or atrioventricular (AV) sequential pacing were compared with intervals measured by the standard method of ventricular pacing. VA intervals were 201 +/- 53 ms during ventricular pacing and 224 +/- 52 ms after ventricular extrastimuli during atrial pacing (p = NS). VA intervals were 305 +/- 77 ms after ventricular extrastimuli during AV sequential pacing and were longer than VA intervals during ventricular pacing (p less than 0.001) or after ventricular extrastimuli during atrial pacing (p less than 0.01). Thus, the ventricular extrastimulus technique during AV sequential pacing reveals substantially longer VA intervals than does ventricular pacing and explains why pacemaker-mediated tachycardia might occur when pacemaker atrial refractory periods are designed or programmed according to VA intervals measured only during ventricular pacing.

Initial experience with physiological pacing

Fifty patients, aged 23 to 88 years, with permanent rate-responsive dual chamber pacemakers were studied prospectively for 14.1 +/- 11.4 (S.D.) months after implantation to assess the benefits and complications associated with this technique. In 12 patients the device replaced a ventricular demand pacemaker. Minor complications associated with implantation occurred in one case. Atrial leads required repositioning because of increase in threshold and/or problems of sensing in five cases and ventricular leads in five. There were two patients with symptomatic pacemaker-related arrhythmias necessitating reprogramming; one patient with pacemaker-mediated tachycardia and one with pacemaker autoinhibition. Seven patients have died; one suddenly and possibly related to a pacemaker-triggered arrhythmia. Of 43 living patients, five are now programmed to the ventricular demand mode; two with atrial fibrillation, one with failed atrial lead repositioning, one with persistent sinus tachycardia, and one because of angina pectoris. Thirty-six of the 43 living patients are asymptomatic and a further six are symptomatically improved. All 12 patients changed from ventricular demand pacing have less symptoms. Rate-responsive dual chamber pacing is safe and appears to improve symptoms in most cases. Complications are infrequent and usually easily overcome. This mode of pacing should be considered in all patients with normal sinoatrial function in whom a permanent pacemaker is indicated.

Cardiac pacing in intensive care

Cardiac pacing techniques and equipment have developed dramatically in recent years. Bradycardias and tachycardias may be effectively treated by pacing. Bradyarrhythmias: It is generally accepted that pacing is indicated for a sustained symptomatic bradycardia. Prophylactic pacing for 'high-risk' bundle branch block in acute myocardial infarction is more controversial. A new era in cardiology has been introduced with the advent of 'physiological pacing', i.e. pacing of the heart with the maintenance of atrioventricular synchrony and varying the heart rate according to the body's metabolic leads. Modern pacing systems, which allow the atria and ventricles to contract in sequence, improve cardiac haemodynamics, result in subjective improvement and increase exercise tolerance. There are, however, pacemaker-associated and pacemaker-mediated tachyarrhythmias. Further advances in technology should overcome these problems. Tachyarrhythmias: Intracardiac electrocardiograms are often useful in the diagnosis of tachyarrhythmias, especially wide complex tachycardias. Rapid pacing of the atria in certain supraventricular tachycardias or of the ventricle in ventricular tachycardia is an alternative to cardioversion in many instances. This form of treatment is usually utilised in conjunction with drug therapy.

Physiological versus single-rate ventricular pacing: a double-blind cross-over study

Previous comparisons of physiological and single-rate ventricular pacing are mostly based on open studies. The present investigation was designed to control possible biases of such a study design with the aim to investigate effects of the two pacing modes on maximal and submaximal exercise tolerance and the subjective feeling of well-being of the patients. Forty-four patients treated with atrioventricular synchronous pacemakers for more than 12 months participated in the study. Their pacemakers were randomly programmed to one 3-week long period of ventricular inhibited and a similar period of atrioventricular synchronous ventricular inhibited pacing. Thereafter, they went through echocardiography, symptom-limited maximal exercise test and answered a questionnaire on subjective symptoms. The study was blind since neither the patients nor the physician conducting the exercise tests were informed of pacing mode. The mean maximal exercise tolerance increased 14% (p less than 0.01) on atrioventricular synchronous pacing. Arterial lactate, respiratory rates and perceived exertion ratings during submaximal levels of exercise were higher on ventricular inhibited pacing, as well as symptoms scored during the two 3-week periods. A majority of patients improved their functional class during atrioventricular synchronous pacing and preferred the physiological pacing mode.

Effect of afterload reduction in patients with ventricular and physiological pacing

The effect of afterload reduction was studied in a group of patients who remained breathless or tired after permanent ventricular pacing. Haemodynamic measurements were made before and after giving hydralazine 20 mg intravenously using a triple lumen thermodilution catheter and cuff blood pressure recordings during ventricular pacing at the standard rate of 71/min or an increased rate of 88/min and physiological pacing. Increasing the ventricular pacing rate had no effect on cardiac output as stroke volume fell. Hydralazine produced a greater rise in cardiac output than physiological pacing alone, although peak values were obtained by combining the two. Ventricular pacing produced intermittent large left and right atrial pressure peaks. Physiological pacing produced no such peaks, and mean right and left atrial pressures fell. Hydralazine did not significantly alter atrial pressures. These findings show that in these patients, most of whom had a low cardiac output, afterload reduction with ventricular pacing increased resting cardiac output more than physiological pacing alone. Nevertheless, persistence of high filling pressures despite afterload reduction may limit the potential therapeutic benefit. Care should be taken in extrapolating these data to other patient groups.